060280 — CUREXO Balance Sheet
0.000.00%
- KR₩629bn
- KR₩604bn
- KR₩56bn
Annual balance sheet for CUREXO, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7,576 | 21,081 | 34,783 | 33,481 | 18,688 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13,011 | 18,513 | 22,985 | 16,266 | 26,497 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 50,471 | 75,952 | 90,831 | 87,942 | 87,129 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,864 | 2,741 | 6,638 | 7,852 | 7,264 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 61,306 | 98,398 | 107,370 | 102,583 | 101,138 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 18,271 | 16,589 | 4,933 | 7,936 | 4,211 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 18,404 | 16,717 | 6,941 | 9,203 | 4,889 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 42,902 | 81,681 | 100,429 | 93,381 | 96,249 |
| Total Liabilities & Shareholders' Equity | 61,306 | 98,398 | 107,370 | 102,583 | 101,138 |
| Total Common Shares Outstanding |